Corsants Life Sciences Private Limited
About Corsants Life Sciences Private Limited
Data last updated:
Corsants Life Sciences Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 April 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2010PTC201660. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Suman Tripathi and Nityanand Tripathi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 95 The Kunj Vihar Cghs Ltd Plot No 19 Sector 12 Dwarkanear Radisson Blu Hotel, New Delhi, Delhi, India – 110075.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.24 Lakh, a decline of 23% compared to the previous year. For the same year it recorded a net profit of ₹1.25 Lakh (net margin 10.2%) and EBITDA of ₹1.7 Lakh (EBITDA margin 13.9%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Corsants Life Sciences Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressB – 95 The Kunj Vihar Cghs Ltd Plot No 19 Sector 12 Dwarkanear Radisson Blu Hotel, New Delhi, Delhi, India – 110075
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Corsants Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Corsants Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Corsants Life Sciences Private Limited, buy the company report.
Financials of Corsants Life Sciences Private Limited
FY 2025 filings availableCorsants Life Sciences Private Limited reported revenue of ₹12.24 Lakh (down 23% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 23% in the latest year. EBITDA fell 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.7 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.25 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.9% | ||||
| Net Profit Margin | 10.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Corsants Life Sciences Private Limited, buy the company report.
Board of directors of Corsants Life Sciences Private Limited
Corsants Life Sciences has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suman Tripathi | Director | 16 Apr 2010 | 16 Years 6 Months | Current |
| Nityanand Tripathi Also directs: Cardiosafe Foundation | Director | 16 Apr 2010 | 16 Years 6 Months | Current |
Peer comparison
Corsants Life Sciences Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Fantina Pharma Private Limited | ₹12.33 Lakh (FY 2023) | -29.0% | Sitamarhi, Bihar, India | |||
| Anee Smith Private Limited | ₹12.33 Lakh (FY 2025) | 290.0% | Mohali, Punjab, India | |||
| Sofgel Capsulation Private Limited | ₹12.29 Lakh (FY 2025) | -75.0% | Kanpur, Uttar Pradesh, India | |||
| Corsants Life Sciences Private Limitedthis company | ₹12.24 Lakh (FY 2025) | ₹1.25 Lakh | 10.2% | -23.0% | New Delhi, Delhi, India | |
| Gurukulherbal and Ayurved India Private Limited | ₹12.22 Lakh (FY 2025) | 511.0% | Hardwar, Uttarakhand, India | |||
| Coromandel Indag Products India Limited | ₹12.22 Lakh (FY 2025) | 80.0% | Chennai, Tamil Nadu, India | |||
| Rollex Paints and Chemicals Pvt Ltd | ₹12.19 Lakh (FY 2025) | -33.0% | Cuttack, Odisha, India |
To see the full peer comparison of Corsants Life Sciences Private Limited, buy the company report.
Auditor
Corsants Life Sciences Private Limited is audited by S R P K & CO for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S R P K & CO | FY 2018 | 007488C |
Shareholding
The shareholding of Corsants Life Sciences Private Limited is on record for 4 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Corsants Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Corsants Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Corsants Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Corsants Life Sciences has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Corsants Life Sciences Private Limited, buy the company report.
Recent activity
Corsants Life Sciences Private Limited has 2 board changes on record since 2010: 2 appointments. The latest: Nityanand Tripathi was appointed as Director on 16 Apr 2010.
Frequently asked questions
Corsants Life Sciences is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 April 2010 (16+ years old) and is registered under CIN U24100DL2010PTC201660.
Corsants Life Sciences has 2 current directors:
- Suman Tripathi - Director
- Nityanand Tripathi - Director
The latest financial statements of Corsants Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Corsants Life Sciences has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Corsants Life Sciences is U24100DL2010PTC201660. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Corsants Life Sciences was incorporated on 16 April 2010, making it 16+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Corsants Life Sciences by revenue are Fantina Pharma Private Limited, Anee Smith Private Limited, Sofgel Capsulation Private Limited, Gurukulherbal and Ayurved India Private Limited, Coromandel Indag Products India Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Nityanand Tripathi was appointed as Director on 16 Apr 2010. Suman Tripathi was appointed as Director on 16 Apr 2010.
The registered office of Corsants Life Sciences is at B – 95 The Kunj Vihar Cghs Ltd Plot No 19 Sector 12 Dwarkanear Radisson Blu Hotel, New Delhi, Delhi, India – 110075.
Corsants Life Sciences operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Corsants Life Sciences is compliant as of 06 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
